Similar companies
Income Statement (USD)
Q3 '24 | QoQ | |
---|---|---|
Revenue | 26M | 12.5% |
Gross Profit | 16M | 18.6% |
Cost of Revenue | 9.3M | 3.3% |
Operating expense | 15M | 4.9% |
Net Income | 1.9M | 12620% |
EBITDA | 1.6M | 848.9% |
Balance Sheet (USD)
Q3 '24 | QoQ | |
---|---|---|
Total Assets | 57M | 4.6% |
Total Liabilities | 22M | 5% |
Total Equity | 34M | 11.9% |
Shares Outstanding | 76M | 0.7% |
Cash Flow (USD)
Q3 '24 | QoQ | |
---|---|---|
Cash from operations | 3.5M | 1414% |
Cash from investing | -21,000 | 75% |
Cash from financing | 1M | 74.3% |
EPS
Financial Highlights for Chromadex in Q3 '24
Chromadex reported a revenue of 26M, which is a 12.5% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 16M, marking a 18.6% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 9.3M, a 3.3% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 15M, showing a 4.9% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 1.9M, showing a 12620% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 1.6M, showing a 848.9% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Chromadex with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies.